| Literature DB >> 28415618 |
Xinheng Zhang1,2,3,4, Yiming Yan1,2,3, Xiaoya Lei1,2,3, Aijun Li5, Huanmin Zhang6, Zhenkai Dai1,2,3, Xinjian Li1,2,3, Weiguo Chen1,2,3,4, Wencheng Lin1,2,3,4, Feng Chen1,2,3,4, Jingyun Ma1,2,3,4, Qingmei Xie1,2,3,4.
Abstract
Avian leukosis virus subgroup (ALV-J) is an oncogenic neoplasm-inducing retrovirus that causes significant economic losses in the poultry industry. Recent studies have demonstrated circular RNAs (circRNAs) are implicated in pathogenic processes; however, no research has indicated circRNAs are involved in resistance to disease. In this study, over 1800 circRNAs were detected by circRNA sequencing of liver tissues from ALV-J-resistant (n = 3) and ALV-J-susceptible chickens (n = 3). 32 differentially expressed circRNAs were selected for analyzing including 12 upregulated in ALV-J-resistant chickens and 20 upregulated in ALV-J-susceptible chickens, besides, the top five microRNAs (miRNAs) for 12 upregulated circRNAs in ALV-J-resistant chickens were analyzed. Gene ontology and KEGG pathway analyses were performed for miRNA target genes, the predicted genes were mainly involved in immune pathways. This study provides the first evidence that circRNA alterations are involved in resistance to ALV-J-induced tumor formation. We propose circRNAs may help to mediate tumor induction and development in chickens.Entities:
Keywords: ALV-J-resistant chickens; circular RNA; circular-seq; tumor
Mesh:
Substances:
Year: 2017 PMID: 28415618 PMCID: PMC5471026 DOI: 10.18632/oncotarget.16442
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
Figure 1CircRNA sequencing data
(A) Mapping region distribution within read alignments; (B) Circos plots, outline is the reference genome, inside is the chromosome coverage across all samples.
Figure 2Heap map for the 32 significant differentially expressed circRNAs in ALV-J-resistant chickens
Sample numbers [4], [3] and [26] represent ALV-J-resistant chickens; [8], [14] and [9] represent ALV-J-susceptible chickens. The numbers 0.0, 1.83 and 2.91 on the top represent the expression levels of the circRNAs. Each row represents a circRNA and each column represents one sample. Dendrograms produced by clustering analysis of the samples are shown on the top. Twelve circRNAs were upregulated (red) and 20 were downregulated (green) in ALV-J-resistant chickens compared to ALV-J-susceptible chickens.
The twelve significantly upregulated circRNAs linked to resistance to ALV-J induced tumor formation in chickens
| CircRNA ID | Fold change | chrom | txStart | txEnd riginal | Original Gene | |
|---|---|---|---|---|---|---|
| chr13:15110945-15122920- | 0.0025 | 5.8790 | chr13 | 15110944 | 15122920 | JADE2 |
| chr9:22282452-22289593- | 0.0050 | 4.2395 | chr9 | 22282451 | 22289593 | LEKR1 |
| chr19:6585504-6585731+ | 0.0062 | 4.0622 | chr19 | 6585503 | 6585731 | UbI |
| chr3:105132799-105136715- | 0.0297 | 3.8360 | chr3 | 105132798 | 105136715 | NCOA1 |
| chr1:179476699-179479760+ | 0.0114 | 3.4851 | chr1 | 179476698 | 179479760 | KDELC2 |
| chr15:469774-490727+ | 0.0166 | 3.2521 | chr15 | 469773 | 490727 | PPM1F |
| chr1:194735582-194744050- | 0.0291 | 3.1591 | chr1 | 194735581 | 194744050 | RAB6A |
| chr18:11114003-11114452- | 0.0367 | 2.9598 | chr18 | 11114002 | 11114452 | CASKIN2 |
| chr13:2807735-2827999- | 0.0156 | 2.8263 | chr13 | 2807734 | 2827999 | RANBP17 |
| chr3:43666306-43724228- | 0.0265 | 2.7662 | chr3 | 43666305 | 43724228 | PACRG |
| chr23:5549365-5549645- | 0.0334 | 2.6458 | chr23 | 5549364 | 5549645 | HMGCL |
| chr2:816575-817682+ | 0.0031 | 2.5679 | chr2 | 816574 | 817682 | SMARCC1 |
Figure 3Annotated significant pathways targeted by the miRNA target genes of 12 circRNAs upregulated in ALV-J-resistant chickens
The horizontal axis is the –LgP (logarithm of P-value) for the pathway and the vertical axis is the pathway category. P < 0.05 was considered significant.
Figure 4KEGG pathway analysis for the miRNA target genes of 12 circRNAs upregulated in ALV-J-resistant chickens
The yellow boxes indicate the genes targeted by differentially expressed circRNAs.
Figure 5Validation of the expression of four selected differentially expressed circRNAs identified by circRNA sequencing
(A) Fold change for each circular RNA as indicated by circRNA sequencing; (B) Relative circRNA levels as indicated by qPCR. Bars are mean ± SD (n=3); **P < 0.05.
Predicted miRNAs for 12 differentially expressed circRNAs linked to resistance to ALV-J induced tumor formation in chickens
| CircRNA ID | miRNA | miRNA | miRNA | miRNA | miRNA |
|---|---|---|---|---|---|
| chr13:15110945-15122920- | gga-miR-6634-5p | gga-miR-1649-5p | gga-miR-24-3p | gga-miR-6587-3p | gga-miR-1663-3p |
| chr9:22282452-22289593- | gga-miR-103-2-5p | gga-miR-107-5p | gga-miR-6680-3p | gga-miR-1692 | gga-miR-6577-5p |
| chr19:6585504-6585731+ | gga-miR-3530-3p | gga-miR-6549-5p | gga-miR-1664-5p | gga-miR-1764-5p | gga-miR-193a-5p |
| chr3:105132799-105136715- | gga-miR-7472-3p | gga-miR-138-5p | gga-miR-1625-3p | gga-miR-148a-5p | gga-miR-1680-5p |
| chr1:179476699-179479760+ | gga-miR-6632-5p | gga-miR-153-5p | gga-miR-1705 | gga-miR-1684b-3p | gga-miR-6698-3p |
| chr15:469774-490727+ | gga-miR-2129 | gga-miR-1632-5p | gga-miR-1659 | gga-miR-6698-3p | gga-miR-6598-5p |
| chr1:194735582-194744050- | gga-miR-6660-3p | gga-miR-1662 | gga-miR-15c-5p | gga-miR-15b-5p | gga-miR-1787 |
| chr18:11114003-11114452- | gga-miR-6607-5p | gga-miR-1749-3p | gga-miR-1785 | gga-miR-19b-5p | gga-miR-6545-3p |
| chr13:2807735-2827999- | gga-miR-365b-5p | gga-miR-1756b | gga-miR-217-3p | gga-miR-6690-5p | gga-miR-1771 |
| chr3:43666306-43724228- | gga-miR-146c-3p | gga-miR-130c-5p | gga-miR-211 | gga-miR-204 | gga-miR-6641-5p |
| chr23:5549365-5549645- | gga-miR-6702-5p | gga-miR-1662 | gga-miR-34b-5p | gga-miR-6611-5p | gga-miR-6641-5p |
| chr2:816575-817682+ | gga-miR-6574-5p | gga-miR-6577-5p | gga-miR-1596-5p | gga-miR-1786 | gga-miR-1615 |
Figure 6Predicted biomathematical circRNA-miRNA-gene network for three selected upregulated circRNAs in ALV-J-resistant chickens
Yellow represents circRNAs, green represents miRNAs and pink represents miRNA target genes.